Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Porter

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Human Gene Therapy|May 20, 1996
Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptorsC D Porter, M K Collins, C S Tailor, et al.
Human Gene Therapy|May 1, 1994
Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumorsP M Patel, C L Flemming, C Fisher, et al.
Journal of Virology|August 1, 1997
Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylationY Takeuchi, S H Liong, P D Bieniasz, et al.
Allergologia Et Immunopathologia|January 1, 1991
Gene therapy for X-linked immunodeficienciesC Kinnon, M A O'Reilly, A Pelham, et al.
Nature|January 4, 1996
Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferaseY Takeuchi, C D Porter, K M Strahan, et al.
Human Gene Therapy|October 9, 1999
In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient miceK V Lukacs, C D Porter, O E Pardo, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Human Gene Therapy|May 20, 1996
Comparison of efficiency of infection of human gene therapy target cells via four different retroviral receptorsC D Porter, M K Collins, C S Tailor, et al.
Human Gene Therapy|May 1, 1994
Generation of interleukin-2-secreting melanoma cell populations from resected metastatic tumorsP M Patel, C L Flemming, C Fisher, et al.
Journal of Virology|August 1, 1997
Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylationY Takeuchi, S H Liong, P D Bieniasz, et al.
Allergologia Et Immunopathologia|January 1, 1991
Gene therapy for X-linked immunodeficienciesC Kinnon, M A O'Reilly, A Pelham, et al.
Nature|January 4, 1996
Sensitization of cells and retroviruses to human serum by (alpha 1-3) galactosyltransferaseY Takeuchi, C D Porter, K M Strahan, et al.
Human Gene Therapy|October 9, 1999
In vivo transfer of bacterial marker genes results in differing levels of gene expression and tumor progression in immunocompetent and immunodeficient miceK V Lukacs, C D Porter, O E Pardo, et al.
Pageof 4